Emergent BioSolutions EBS
NYSE EBS
$6.29 -0.07 (-1.10%)
As of: Oct 20, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026)

Updated

Emergent BioSolutions' Operating Expenses was $359.4 million in Q2 2026, up 158.0% from $139.3 million a year earlier and up 146.8% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Emergent BioSolutions' Operating Expenses was $836.2 million through Jun 30, 2026, up 12.2% year-over-year; for FY2025, it was $642.8 million, down 44.2% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of -10.8% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $1.15 billion in FY2024 (-35.1%), $1.78 billion in FY2023 (+37.9%), $1.29 billion in FY2022 (-10.1%) and $1.43 billion in FY2021 (+25.8%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses since Q2 2024.
  • Compared with a year earlier, Operating Expenses was higher in 1 of the last eight quarters, with an average decline of 12.3%.
  • The best year-over-year quarter for Operating Expenses over five years was Q2 2026 (growth of 158.0%); the worst was Q2 2025 (a decline of 69.6%).
  • Per Business Quant data, EBS's Operating Expenses in the three quarters before Q2 2026 was $145.6 million (Q1 2026), $176.6 million (Q4 2025) and $154.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 10.12 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 10.56 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 9.70 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 18.20 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 6.68 Bn
10 Emergent BioSolutions 325.34 Mn -425.56 Mn 137.20 Mn 359.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 359.40 Mn
Mar 31, 2026 145.60 Mn
Dec 31, 2025 176.60 Mn
Sep 30, 2025 154.60 Mn
Jun 30, 2025 139.30 Mn
Mar 31, 2025 172.30 Mn
Dec 31, 2024 204.20 Mn
Sep 30, 2024 229.30 Mn
Jun 30, 2024 458.20 Mn
Mar 31, 2024 260.60 Mn
Dec 31, 2023 320.40 Mn
Sep 30, 2023 512.60 Mn
Jun 30, 2023 630.80 Mn
Mar 31, 2023 311.90 Mn
Dec 31, 2022 385.50 Mn
Sep 30, 2022 285.20 Mn
Jun 30, 2022 314.70 Mn
Mar 31, 2022 301.10 Mn
Dec 31, 2021 437.90 Mn
Sep 30, 2021 363.70 Mn
API Access

Emergent BioSolutions Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY